Skip to main content
Premium Trial:

Request an Annual Quote

With Support of GSK, Canadian Researchers Launch New Proteomics Study

NEW YORK, July 11 – A Canadian consortium supported by GlaxoSmithKline has launched a proteomics study that will look at whether it is possible to use fruit flies to screen for human drugs.

Alan Bernstein, president of the Canadian Institutes of Health Research, Paul Lucas, president of GlaxoSmithKline, and Heather Munroe-Blum, vice president of research and international relations at the University of Toronto, said in a joint statement issued Tuesday that the $1.5 million, two-year study would search for novel ways to control proteins behavior. 

The researchers hope that by studying the nuclear receptor family of the fruit fly, they will be able to gain new knowledge about human biology and disease.

"Today's announcement and partnership is another milestone in our ongoing commitment to support innovative Canadian research and development, encouraging the world's brightest researchers and scientists to conduct their important discovery work in Canada,” Lucas said.

The project is being funded through a partnership between GlaxoSmithKline and CIHR.

The participants in the project did not disclose where the research would take place and who would own the rights to the findings. 

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.